13h
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 TrialConstructive Type C Meeting Provides Potential Pathway to Accelerated ...
A research team from the Institute of Modern Physics of the Chinese Academy of Sciences and Lanzhou University has obtained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback